Actual Medicinal Product (AMP) Asacol 400mg MR gastro-resistant tablets (AbbVie Ltd)
Stability Information
- Stability
-
Medicines suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.
- Notes
-
If the desiccant is removed, or the tablets are dispensed in alternative packaging without the desiccant, the tablets will be stable for at least six months (or to the expiry date of the original container).
- Generic
- Mesalazine
- Formulation
- Mesalazine 400mg gastro-resistant tablets
-
Mesalazine
-
Mesalazine 400mg gastro-resistant tablets
-
Asacol 400mg MR gastro-resistant tablets (AbbVie Ltd)
-
-
Asacol 400mg MR gastro-resistant tablets (Sigma Pharmaceuticals Plc)
Mesalazine 250mg gastro-resistant tablets